AC Immune (ACIU) Receivables - Other (2014 - 2026)
AC Immune (ACIU) posted quarterly Receivables - Other of $1.6 billion for Q1 2026, up 73939.16% year-over-year from N/an in Q1 2025, and up 33.79% quarter-over-quarter from $1.2 billion in Q4 2025.
AC Immune (ACIU) Receivables - Other (2014 - 2026) Analysis & Trends
AC Immune (ACIU) has reported Receivables - Other for 13 consecutive years, with $1.6 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables - Other rose 73939.16% year-over-year to $1.6 billion; the TTM figure through Mar 2026 stood at $1.6 billion (up 73939.16% YoY), while the FY2025 annual figure was $1.2 billion, up 93500.71% from the prior year.
- Receivables - Other climbed to $1.6 billion in Q1 2026 per ACIU's latest filing, from $1.2 billion in the prior quarter.
- Across five years, Receivables - Other topped out at $1.6 billion in Q1 2026 and bottomed at $336989.2 in Q2 2023.
- Historically, Receivables - Other has averaged $206.7 million across 5 years, with a median of $1.3 million in 2024.
- Annual changes were most pronounced in 2022 — Receivables - Other tumbled 99.91% — and 2025, when it jumped 96996.1%.
- AC Immune's Receivables - Other stood at $406904.6 in 2022, then soared by 72.33% to $701214.5 in 2023, then surged by 79.72% to $1.3 million in 2024, then surged by 96996.1% to $1.2 billion in 2025, then jumped by 33.79% to $1.6 billion in 2026.
- Business Quant data shows ACIU's Receivables - Other at $1.6 billion in Q1 2026, $1.2 billion in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | AC Immune | 253.89 Mn | 253.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.45 Mn |
| Jun 30, 2026 | 4.45 Mn |
| Mar 31, 2026 | 1.64 Bn |
| Mar 31, 2026 | 1.64 Bn |
| Dec 31, 2025 | 1.22 Bn |
| Dec 31, 2025 | 1.22 Bn |
| Sep 30, 2025 | 1.98 Mn |
| Sep 30, 2025 | 1.98 Mn |
| Jun 30, 2025 | 1.96 Mn |
| Jun 30, 2025 | 1.96 Mn |
| Mar 31, 2025 | 2.21 Mn |
| Mar 31, 2025 | 2.21 Mn |
| Dec 31, 2024 | 1.26 Mn |
| Dec 31, 2024 | 1.26 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.27 Mn |
| Jun 30, 2024 | 1.27 Mn |
| Mar 31, 2024 | 994,452.25 |
| Mar 31, 2024 | 994,452.25 |